Ready-made ETF portfolios built for real investor needs. Explore now →

Advertisement
Advertisement

PJPvsFTXHETF Comparison

ETF 1
PJP

Invesco Dynamic Pharmaceuticals ETF

This fund is part of
US Health Care
+1.21%
VS
ETF 2
FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of
US Health Care
+1.21%

Invesco Dynamic Pharmaceuticals ETF (PJP) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. Both ETFs have the same top 1 sector exposures: Healthcare. PJP is less expensive with a Total Expense Ratio (TER) of 0.58%, versus 0.6% for FTXH. PJP is up 20.18% year-to-date (YTD) with +$166M in YTD flows. FTXH performs better with 23.24% YTD performance, and +$978M in YTD flows. Run a side-by-side ETF comparison of PJP and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PJP vs FTXH performance and flow charts

Performance

0.02.04.06.08.0%Aug 11Aug 18Aug 25Sep 1Sep 9

Cumulative Flows

0 M10 M20 M30 M40 MAug 11Aug 18Aug 25Sep 1Sep 9

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/14/2026
1M3MYTD1Y3Y5Y
Perf.
PJP
FTXH
-0.27%+1.24%
+10.81%+12.41%
+20.18%+23.24%
+38.79%+43.67%
+67.59%+58.09%
+66.54%+67.31%
Flows
PJP
FTXH
+$36M+$41M
+$158M+$968M
+$166M+$978M
+$180M+$981M
+$114M+$973M
-$33M+$977M
Volatility and drawdown
3M1Y3Y5Y
Volatility
PJP
FTXH
+18.23%+19.73%
+17.04%+17.65%
+16.36%+16.98%
+16.47%+16.34%
Max drawdown
PJP
FTXH
-5.67%-5.41%
-9.42%-7.50%
-16.11%-19.32%
-17.41%-19.32%
Max drawdown duration
PJP
FTXH
26d17d
108d99d
275d393d
788d393d
Trading data

Create an account to view trading data

Join for free
PJP
FTXH
Last sale
9/15/2026 at 1:30 PM
$123.76
$40.69
Previous close
09/14/2026
$124.96
$40.72
Consolidated volume
09/14/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PJP
FTXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/15/2026 at 1:30 PM
Live
Closed
PJP
FTXH
Last price
$123.76
$40.69
1D performance
-0.96%
-0.07%
AuM$547.22 M$1.04 B
E/R0.58%0.6%
Characteristics
PJP
FTXH
Management strategyPassivePassive
ProviderInvescoFirst Trust
BenchmarkDynamic Pharmaceutical Intellidex IndexNASDAQ US Smart Pharmaceuticals Index
N° of holdings2849
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 23, 2005September 20, 2016
ESGNoNo
Advertisement
Exposure

Countries

PJP
USA
94.69%
Other
5.31%
FTXH
USA
95.79%
Other
4.21%

Sectors

PJP
Healthcare
100%
Other
-0%
FTXH
Healthcare
99.86%
Other
0.14%
Advertisement

Diversification

PJP

Total weight of top 15 holdings out of 15

65.5%
FTXH

Total weight of top 15 holdings out of 15

66.98%

Top 15 holdings

Data as of July 31, 2026
PJP
Abbott Laboratories
5.76%
AbbVie, Inc.
5.71%
Amgen, Inc.
5.33%
Johnson & Johnson
5.33%
Eli Lilly & Co.
5.25%
Merck & Co., Inc.
5.03%
Gilead Sciences, Inc.
4.58%
Pfizer Inc.
4.49%
Corcept Therapeutics, Inc.
4.00%
Amneal Pharmaceuticals, Inc.
3.88%
Liquidia Corp.
3.75%
Travere Therapeutics, Inc.
3.26%
Ligand Pharmaceuticals, Inc.
3.18%
Harmony Biosciences Holdings, Inc.
3.10%
Viatris, Inc.
2.85%
FTXH
Merck & Co., Inc.
7.58%
Eli Lilly & Co.
7.43%
AbbVie, Inc.
7.11%
Johnson & Johnson
6.78%
Bristol Myers Squibb Co.
6.61%
Amgen, Inc.
3.53%
Biogen, Inc.
3.52%
Vertex Pharmaceuticals, Inc.
3.43%
Viatris, Inc.
3.40%
Regeneron Pharmaceuticals, Inc.
3.34%
Pfizer Inc.
3.17%
Cardinal Health, Inc.
3.14%
Gilead Sciences, Inc.
3.03%
Incyte Corp.
2.48%
United Therapeutics Corp.
2.43%
Frequently asked questions about PJP and FTXH

How have the PJP and FTXH ETFs performed in 2026?

As of September 14, 2026, PJP is up 20.18% year-to-date (YTD), while FTXH has returned 23.24%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: PJP or FTXH?

Year-to-date, the PJP ETF saw +$166M in flows, compared to +$978M for FTXH.

Which ETF is more volatile: PJP or FTXH?

Over the past year, PJP had a volatility of 17.04%, while FTXH experienced 17.65%.

Which ETF is bigger: PJP or FTXH?

As of September 14, 2026, PJP holds $547.22 M in assets under management (AUM), while FTXH manages $1.04 B.

What sectors do the PJP and FTXH ETFs invest in?

PJP leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the PJP ETF and FTXH ETF?

PJP top holdings include Abbott Laboratories, AbbVie, Inc. and Amgen, Inc.. FTXH holds in its top three: Merck & Co., Inc., Eli Lilly & Co. and AbbVie, Inc..

Which ETF is more diversified: PJP or FTXH?

PJP holds 28 securities with 65.5% of its assets in the top 15. FTXH has 49 securities and a top 15 weight of 66.98%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder